Authors : Muhammad Zubair; Pankaj Kishor Mishra; Saurabh Singhal

Volume/Issue : Volume 11 - 2026, Issue 10 - October

Google Scholar : https://tinyurl.com/46w355m9

DOI : https://doi.org/10.38124/ijisrt/26Oct953

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Despite the many adverse effects of conventional pharmacology, the poor therapeutic response of these drugs and poor adherence to therapy by patients, hypertension still continues to be a major cause of cardiovascular morbidity and mortality worldwide. There is increasing evidence that many plant-derived compounds have potent antihypertensive properties through a variety of mechanisms including ACE inhibition, vasodilation, reduction in oxidative stress, restoration of endothelial function and autonomic nervous system modulation. It is a comprehensive assessment of the phytochemical composition, pharmacological mechanisms, preclinical and clinical investigations and translatability of some of the major medicinal plants with antihypertensive activity. We discuss research on garlic (Allium sativum), hibiscus (Hibiscus sabdariffa), hawthorn (Crataegus species), green tea (Camellia sinensis), olive leaf (Olea europaea), arjuna (Terminalia arjuna), ginseng (Panax ginseng), ashwagandha (Withania somnifera), curcumin (Curcuma longa), and other botanicals with potential cardiovascular benefits. It is important to address the standardization problems, bioavailabilities concerns, drug interaction and regulatory issues that constitute the major impediments to clinical translation. The future possibilities of precision phytomedicine, systems pharmacology and the integration of plant-derived therapeutics into evidence-based cardiovascular treatments are discussed, along with new technology developments based on nanotechnology to deliver phytochemicals. From this study, it can be concluded that plant medicines have great potential as complementary medicines for the treatment of hypertension, but more multicenter clinical trials and chemistry standardisation procedures and mechanistic validation are needed for their general clinical application. Combination of old remedies of the plant kingdom with the newest developments of molecular pharmacology offers plenty of scope for developing novel multi-target antihypertensive agents with improved safety and tolerability.

Keywords : Hypertension, Phytotherapy, Medicinal Plants, Antihypertensive Mechanisms, Phytochemicals, Cardiovascular Pharmacology, Natural Products, Standardization, Clinical Translation, Nanotechnology.

References :

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK & He J (2005) Lancet, 365(9455), 217-223.
2. Mancia G, Fagard R, Narkiewicz K et al. (2013) 2013 Eur Heart J, 34(28), 2159-2219.
3. Whelton PK, Carey RM, Aronow WS et al. (2017) J Am Coll Cardiol, 71(19), e127-e248.
4. Lim SS, Vos T, Flaxman AD et al. (2012) Lancet, 380(9859), 2224-2260.
5. Guedes MV, de Araujo TL, Lopes MV, da Silva Lde F, de Freitas MC & de Almeida PC (2011) Rev Bras Enferm. 64(6), 1038-1042. d
6. Reid K, Frank OR & Stocks NP (2009) BMC Complement Altern Med, 9, 22.
7. Beulens JW, Booth SL, van den Heuvel EG, Stoecklin E, Baka A & Vermeer C (2013) Thromb Haemost, 110(04), 685-693.
8. Rahman K (2007) Clin Interv Aging, 2(2), 219-236.
9. Banerjee SK & Maulik SK (2002) Nutr J, 1(1), 4.
10. Izzo AA & Ernst E (2009) Drugs, 69(13), 1777-1798.
11. Qammar NW, Orinaite U, Siauciunaite V, Vainoras A, Sakalyte G & Ragulskis M (2022) Diagnostics (Basel). 12(5),1256.
12. Ried K, Frank OR, Stocks NP, Fakler P & Sullivan T (2008) BMC Cardiovasc Disord, 8(1), 13.
13. Schiffrin EL, Lipman ML & Mann JF (2007) Circulation, 116(8), 974-983.
14. Endemann DH & Schiffrin EL (2004) J Am Soc Nephrol, 15(8), 1983-1992.
15. Vanhoutte PM, Feletou M & Taddei S (2005) Br J Pharmacol. 144(4), 449-458.
16. Forstermann U & Munzel T (2006) Circulation, 113(13), 1708-1714.
17. Brandes RP, Fleming I & Busse R (2005) Cardiovasc Res, 66(2), 286-294.
18. Griendling KK & FitzGerald GA (2003) Circulation, 108(16), 1912-1916.
19. Teegarden D, Lyle RM, McCabe GP, McCabe LD, Proulx WR, Michon K, Knight AP, Johnston CC & Weaver CM (1998) Am J Clin Nutr, 68(3), 749-54.
20. Katz DL, Davidhi A, Ma Y, Kavak Y, Bifulco L & Njike VY (2012) J Am Coll Nutr, 31(6), 415-23.
21. Oka Y, Jiroumaru T, Hyodo Y, Kuroda M, Murata R & Fujikawa T (2025) Cureus, 17(7), e88089.
22. Xiao L & Harrison DG (2020) Can J Cardiol, 36(5), 635-647.
23. Choi HY, Park HC & Ha SK (2015) 13(1), 7-16.
24. Zhu Y, Chen J, Li J, Zhou C, Huang X & Chen B (2023) Front Immunol, 14, 1070679.
25. Li Y, Long J, Li L, Yu Z, Liang Y, Hou B, Xiang L & Niu X (2023 Exp Ther Med, 26(5), 522.
26. Fujita T, Henry WL, Bartter FC, Lake CR & Delea CS (1980) Am J Med, 69(3), 334-344.
27. Lohmeier TE & Iliescu R (2011) Hypertension, 57(5), 880-886.
28. Schwartzkopff B, Mundhenke M & Strauer BE (1998) J Am Coll Cardiol. 31(5),1089-1096.
29. Catterall WA (2000) Annu Rev Cell Dev Biol, 16, 521-555.
30. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ & Sato K (1997) Pharmacol Rev, 49(2), 157-230.
31. Matsunaga N, Chikaraishi Y, Shimazawa M, Yokota S, & Hara H (2010) Evid Based Complement Alternat Med, 7(1), 47-56.
32. Grassi D, Socci V, Tempesta D, Ferri C, De Gennaro L, Desideri G & Ferrara M (2016) J Hypertens, 34(7), 1298-308.
33. Engler MB, Engler MM, Chen CY, Malloy MJ, Browne A, Chiu EY, Kwak HK, Milbury P, Paul SM, Blumberg J & Mietus-Snyder ML (2004) J Am Coll Nutr, 23(3), 197-204.
34. Hollenberg NK, Martinez G, McCullough M, Meinking T, Passan D, Preston M, Rivera A, Taplin D & Vicaria-Clement M (1997) Hypertension, 29(1), 171-176.
35. Cassidy A, Rimm EB, O'Reilly EJ, Logroscino G, Kay C, Chiuve SE & Rexrode KM (2012) Stroke, 43(4), 946-951.
36. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT & Weber KT (2002) Am J Pathol. 161(5), 1773-81.
37. Katz DL & Gonzalez MH (2002). Sourcebooks Inc.
38. Hopkins AL, Lamm MG, Funk JL & Ritenbaugh C (2013) Fitoterapia, 85, 84-94.
39. Katz DL, Njike VY, Faridi Z, Rhee LQ, Reeves RS, Jenkins DJ & Ayoob KT (2009) Am J Health Promot. 24(2), 133-43.
40. Lopez-Miranda J, Perez-Jimenez F, Ros E, et al. (2010) Nutr Metab Cardiovasc Dis, 20(4), 284-294.
41. Feng S, Zhang C, Chen T, Zhou L, Huang Y, Yuan M, Li, T, & Ding, C (2021) Antioxidants (Basel, Switzerland), 10(11), 1697.
42. Acheson KJ, Gremaud G, Meirim I, Montigon F, Krebs Y, Fay LB, Gay LJ, Schneiter P, Schindler C & Tappy L (2004) Am J Clin Nutr, 79(1), 40-46.
43. Srivastava KC, Bordia A & Verma SK (1995) Prostaglandins Leukot Essent Fatty Acids, 52(4), 223-227.
44. Aggarwal BB & Sung B (2009) Trends Pharmacol Sci, 30(2), 85-94.
45. Hallajzadeh J, Milajerdi A, Kolahdooz F, Amirani E, Mirzaei H & Asemi Z (2019) Phytother Res. 33(11), 2989-2995.
46. Szikora Z, Matyus RO, Szabo BV, Csupor D, & Toth B (2025) Pharmaceuticals (Basel), 18(7),1027.
47. Ernst E & Pittler MH (2000) Br J Anaesth 84(3), 367-71.
48. Yancy WS, Olsen MK, Guyton JR, Bakst RP, & Westman EC (2004). Annals of Internal Medicine, 140(10), 769–777.
49. Khorrami Chokami K, Khorrami Chokami A, Cammarata G, Piras G, Albertelli M, Gatto F, Vera L, Ferone D & Boschetti M (2024) J Transl Med. 22(1), 536.
50. Mozaffarian D, Appel LJ, Van Horn L (2011) Circulation, 123(24), 2870-2891.
51. Khan A, Safdar M, Ali Khan MM, Khattak KN & Anderson RA (2003) Diabetes Care, 26(12), 3215-3218.
52. Svetkey LP, Sacks FM, Obarzanek E, Vollmer WM, Appel LJ, Lin PH, Karanja NM, Harsha DW, Bray GA, Aickin M, Proschan MA, Windhauser MM, Swain JF, McCarron PB, Rhodes DG & Laws RL (1999) J Am Diet Assoc. 99(8), S96-104.
53. Appel LJ, Champagne CM, Harsha DW, Cooper LS, Obarzanek E, Elmer PJ, Stevens VJ, Vollmer WM, Lin PH, Svetkey LP, Stedman SW & Young DR (2003) JAMA, 289(16), 2083-2093.
54. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N & Lin PH (2001) N Engl J Med, 344(1), 3-10.
55. Whelton SP, Chin A, Xin X & He J (2002) Ann Intern Med, 136(7), 493-503.
56. Lewis RP, Bristow JD & Griswold HE (1970) Am Heart J, 80(2):171-6.
57. Coffman TM (2014) J Clin Invest, 124(6), 2341-2347.
58. Dwivedi S & Chopra D (2014) J Tradit Complement Med, 4(4), 224-31.
59. Priya N, Mathur KC, Sharma A, Agrawal RP, Agarwal V & Acharya J (2019) Advances in Human Biology. 9(1), 98-101.
60. Manna P & Sinha M, Sil PC (2006) BMC Complement Altern Med, 6, 33.
61. Kim JH (2012) J Ginseng Res, 36(1):16-26.
62. Buettner C, Yeh GY, Phillips RS, Mittleman MA & Kaptchuk TJ (2006) Ann Pharmacother. 40(1):83-95.
63. Park SH, Chung S, Chung MY, Choi HK, Hwang JT & Park JH (2022) J Ginseng Res, 46(2):188-205.
64. Kim KH, Lee D, Lee HL, Kim CE, Jung K & Kang KS (2018) J Ginseng Res. 42(3), 239-247.
65. Dar NJ, Hamid A & Ahmad M (2015) Cell Mol Life Sci, 72(23), 4445-60.
66. Lopresti AL, Smith SJ, Malvi H & Kodgule R (2019) Medicine (Baltimore), 98(37), e17186.
67. Sharma AK, Basu I & Singh S (2018) J. Altern. Complement. Med (New York, N.Y.) 24(3):243-248.
68. Tandon N & Yadav DK (2020) Phytomedicine, 15(8-9), 531-535.
69. Aggarwal BB, & Harikumar KB (2009) Int J Biochem Cell Biol. 41(1),40-59.
70. Gupta SC, Patchva S & Aggarwal BB (2013) AAPS J, 15(1), 195-218.
71. Panahi Y, Khalili N, Sahebi E, Namazi S, Reiner Z, Majeed M & Sahebkar A (2017) Complement Ther Med, 33, 1-5.
72. Chainani-Wu N (2003) J Altern Complement Med, 9(1), 161-168.
73. Khan A, Safdar M, Ali Khan MM, Khattak KN & Anderson RA (2003) Diabetes Care, 26(12), 3215-3218.
74. Ferizi R, Ramadan MF & Maxhuni Q (2023) J Pharm Bioallied Sci, 15(2), 63-67.
75. Leone A, Spada A, Battezzati A, Schiraldi A, Aristil J & Bertoli S (2015) Int J Mol Sci, 16(6), 12791-12835.
76. Liu Y, Han Z, Li X, Tang Y, Wang B, Song Z & Shi J (2026) Pestic. Biochem. Physiol, 218:106947.
77. Corti R, Flammer AJ, Hollenberg NK & Luscher TF (2009) Circulation, 119(10), 1433-1441.
78. Al-Dujaili EA & Smail N (2012) Endocr Abstr, 28, 313.
79. Katz DL (2011) Int J Obes (Lond), 35(1), 33-37.
80. Michalska M, Gluba A, Mikhailidis DP, Nowak P, Bielecka-Dabrowa A, Rysz J & Banach M (2010) Med Sci Monit, 16(5), RA110-9.
81. Vaya J & Mahmood S. (2006) Biofactors, 28(3-4), 169-75.
82. Lagouge M, Argmann C, Gerhart-Hines Z, et al. (2006) Cell, 127(6), 1109-1122.
83. Kensler TW, Wakabayashi N & Biswal S (2007) Annu Rev Pharmacol Toxicol, 47, 89-116.
84. Savini I, Catani MV, Evangelista D, Gasperi V & Avigliano L (2013) Int J Mol Sci, 14(5), 10497-10538.
85. Choi CW, Kim SC, Hwang SS, et al. (2002) Plant Sci, 163(6), 1161-1168.
86. Higgins JP, Altman DG, Gøtzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L & Sterne JA (2011) Version 5.1.0. Cochrane Collaboration.
87. Moher D, Liberati A, Tetzlaff J & Altman DG PRISMA Group (2009) BMJ, 339, b2535.
88. Schunk SJ & Zimmermann P (2025) J Clin Med, 14(13), 4567.
89. Haider F, Ghafoor H, Hassan OF, Farooqui K, Bel Khair AOM & Shoaib F (2023) Cureus, 15(11), e49734.
90. Calixto JB (2000) Braz J Med Biol Res, 33(2), 179-189.
91. T P A, M SS, Jose A, Chandran L & Zachariah SM (2009) J Clin Med Res, 1(4):191-4.
92. Benzie IFF & Wachtel-Galor S, 2011 CRC Press/Taylor & Francis, PMID: 22593937.
93. Goel A, Kumar M & Kaushik R (2026). Research Gate, 11, 130-142
94. Anand P, Kunnumakkara AB, Newman RA & Aggarwal BB (2007) Mol Pharm, 4(6), 807-818.
95. Letchford K & Burt H (2007) Eur J Pharm Biopharm, 65(3), 259-269.
96. Camicioli R (2008) Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 35. 687-688.
97. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cui Y & Ang CY (2005) Drugs Aging, 22(6), 525-39.
98. Mills E, Wu P, Johnston BC, Gallicano K, Clarke M & Guyatt G (2005) Ther Drug Monit, 27(5), 549-57.
99. Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL & Zhou S (2005) Drugs, 65(9), 1239-1282.
100. Schulz KF, Altman DG & Moher D (2010) BMJ, 340, c332.
101. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D & Moher D. (2013) Ann Intern Med, 158(3), 200-207.
102. Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, Habtemariam S & Shin HS (2018) J Nanobiotechnol, 16(1), 71.
103. Cao L, Zhu Y, Wang W, Wang G, Zhang S & Cheng H (2021) Front Bioeng Biotechnol. 9,798882.
104. Oleiwi SS & Hameed GS (2026) Al-Rafidain Journal of Medical Sciences 10(1), 254–264.
105. Majumder N, G Das N & Das SK (2020) 11(10), 613-635.
106. Bangham AD (1993) Chem Phys Lipids, 64(1-3), 275-285.
107. Hopkins AL (2008) Nat Chem Biol. 4(11), 682-90.
108. Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, Reich M, Hieronymus H, Wei G, Armstrong SA, Haggarty SJ, Clemons PA, Wei R, Carr SA, Lander ES & Golub TR (2006) Science, 313(5795), 1929-1935.
109. Evans WE & Relling MV (2004) Nature, 429(6990), 464-468.
110. Barabasi AL & Oltvai ZN (2004) Nat Rev Genet, 5(2), 101-113.
111. Kitano H (2002) Science, 295(5560), 1662-1664.
112. Chang CH, Lin CH, Lane HY (2021) Disease. Int J Mol Sci, 22(5), 2761.
113. Patel L, Shukla T, Huang X, Ussery DW, Wang S (2020) Molecules, 25(22), 5277.
114. Ekins S, Mestres J, Testa B (2007) Br J Pharmacol, 152(1), 9-20.
115. Witkowska D, Sowik J, Chilicka K (2021) Molecules, 26(19), 6060.
116. Mozaffarian D, Appel LJ, Van Horn L (2011) Circulation, 123(24), 2870-2891.